Dermatology NewsSustained response at 2 years reported for newly approved oral psoriasis agentSeptember 15, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsTargeted anti-IgE therapy found safe and effective for chronic urticariaSeptember 14, 2022Mixed Topics
Dermatology NewsNot just what, but when: Neoadjuvant pembrolizumab in melanomaSeptember 14, 2022Melanoma
Dermatology News‘Smoking gun–level’ evidence found linking air pollution with lung cancerSeptember 14, 2022Melanoma
Optimizing Narrowband UVB Phototherapy: Is It More Challenging for Your Older Patients?September 14, 2022Contact DermatitisAtopic DermatitisPsoriasis
Dermatology NewsFDA warns of cancer risk in scar tissue around breast implantsSeptember 14, 2022Nonmelanoma Skin CancerMixed Topics
Dermatology NewsLitifilimab meets primary endpoint in phase 2 lupus trialSeptember 13, 2022Autoimmune Diseases
Dermatology NewsRoflumilast foam effectively eases seborrheic dermatitisSeptember 13, 2022Medical DermatologyAtopic Dermatitis
Dermatology NewsDupilumab offers ‘clinically meaningful’ improvements in prurigo nodularisSeptember 13, 2022Medical DermatologyAtopic Dermatitis
Dermatology NewsDermatoses often occur in people who wear face masksSeptember 13, 2022Contact DermatitisCOVID-19 Updates
Dermatology NewsFDA approves oral TYK2 inhibitor deucravacitinib for treating psoriasisSeptember 12, 2022PsoriasisPsoriatic Arthritis
